Rzany Berthold, Cartier Hugues, Kestermont Philippe, Trevidic Patrick, Sattler Gerhard, Kerrouche Nabil, Dhuin Jean-Charles
Division of Evidence Based Medicine, Charité-Universitätsmedizin, Berlin, Germany.
J Drugs Dermatol. 2012 Jan;11(1 Suppl):s27-34.
The periorbital region is a challenging area for injectable filler. Overcorrection and/or the use of unsuitable fillers may lead to unwanted results. As evidence for this region is limited, most physicians follow a trial and error approach.
Assess the efficacy, patient satisfaction, and safety of the HA E filler range in periorbital rejuvenation.
This was a multi-center, six-month, open-label study. Subjects could receive HA E Touch, HA E Classic, and HA E Deep for the treatment of tear troughs and periorbital lines at baseline, and an optional touch-up three weeks later. Global aesthetic improvement for both indications, periorbital wrinkle assessments (Lemperle Rating Scale), 3-D volume analysis (for tear troughs only), adverse events and injection site reactions were evaluated at each visit. A subject satisfaction questionnaire was performed three weeks after last injection.
Overall, HA E Classic and Deep were infected for tear troughs, and HA E Touch for periorbital lines. Mean aesthetic improvement in tear troughs was 1.5-2 grades for both products at each post-baseline visit, and results of the clinical evaluation were confirmed by results of 3-D volume analysis. Improvements of periorbital lines in both aesthetic outcomes and wrinkle severity were around 1.5 grades at week 3, and close to 1 grade at month 6. The majority of subjects were satisfied or very satisfied with their aesthetic outcome. Treatments of both indications were safe and well-tolerated, with only mild and transient injection site reactions reported.
This HA E filler range is suitable for rejuvenation of the periorbital region, which leads to safe results, long-lasting efficacy and high levels of patient satisfaction.
眶周区域是注射填充剂应用的一个具有挑战性的部位。过度矫正和/或使用不合适的填充剂可能会导致不理想的结果。由于该区域的相关证据有限,大多数医生采用试错法。
评估HA E系列填充剂在眶周年轻化中的疗效、患者满意度和安全性。
这是一项为期六个月的多中心开放标签研究。受试者在基线时可接受HA E Touch、HA E Classic和HA E Deep治疗泪沟和眶周纹,并在三周后可选择进行补充注射。每次随访时评估两种适应症的整体美学改善情况、眶周皱纹评估(Lemperle评分量表)、三维体积分析(仅针对泪沟)、不良事件和注射部位反应。在最后一次注射三周后进行受试者满意度问卷调查。
总体而言,HA E Classic和Deep用于治疗泪沟,HA E Touch用于治疗眶周纹。两种产品在每次基线后随访时,泪沟的平均美学改善为1.5至2级,临床评估结果得到三维体积分析结果的证实。眶周纹在美学效果和皱纹严重程度方面的改善在第3周时约为1.5级,在第6个月时接近1级。大多数受试者对其美学效果感到满意或非常满意。两种适应症的治疗均安全且耐受性良好,仅报告了轻微和短暂的注射部位反应。
该HA E系列填充剂适用于眶周区域的年轻化,可带来安全的效果、持久的疗效和较高的患者满意度。